Largest Biotechnology companies in Switzerland by Market Capitalization
Switzerland
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 197.34 B |
Jan. 14, 2025 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 2 |
USD 42.45 B |
Jan. 14, 2025 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 3 |
USD 25.92 B |
Jan. 14, 2025 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 4 |
USD 18.51 B |
Jan. 14, 2025 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 5 |
USD 4.85 B |
Jan. 14, 2025 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 6 |
USD 4.57 B |
Jan. 14, 2025 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 7 |
USD 4.52 B |
Jan. 14, 2025 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 8 |
USD 3.27 B |
Jan. 14, 2025 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 9 |
USD 3.17 B |
Jan. 14, 2025 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 10 |
USD 3.14 B |
Jan. 14, 2025 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 11 |
USD 2.93 B |
Jan. 14, 2025 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 12 |
USD 2.29 B |
Jan. 14, 2025 | USD 41.74 | 4.19% |
|
Switzerland |
|
| 13 |
USD 941.25 M |
Jan. 14, 2025 | USD 22.44 | 0.27% |
|
Switzerland |
|
| 14 |
USD 923.14 M |
Jan. 14, 2025 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 15 |
USD 911.45 M |
Jan. 14, 2025 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 16 |
USD 539.74 M |
Jan. 14, 2025 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 17 |
USD 518.05 M |
Jan. 14, 2025 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 18 |
USD 258.24 M |
Jan. 14, 2025 | USD 2.61 | NA |
|
Switzerland |
|
| 19 |
USD 201.90 M |
Jan. 14, 2025 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 20 |
USD 165.34 M |
Jan. 14, 2025 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 21 |
USD 76.25 M |
Jan. 14, 2025 | USD 2.41 | 0.50% |
|
Switzerland |
|
| 22 |
USD 8.27 M |
Jan. 14, 2025 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 23 |
USD 5.60 M |
Jan. 14, 2025 | USD 2.03 | -1.93% |
|
Switzerland |
Frequently Asked Questions
-
Which Biotechnology company in Switzerland has the highest Market Capitalization ?
The Biotechnology company in Switzerland with the highest Market Capitalization is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD 197.34 B.
-
Which Biotechnology company in Switzerland has the lowest Market Capitalization ?
The Biotechnology company in Switzerland with the lowest Market Capitalization is NLS Pharmaceutics AG (NasdaqCM: NLSP) at USD 5.60 M.
-
What are the top 10 Biotechnology companies in Switzerland by Market Capitalization ?
The top 10 Biotechnology companies in Switzerland by Market Capitalization are Novartis AG, Lonza Group AG, DSM-Firmenich AG, Sandoz Group AG, Ypsomed Holding AG, Bachem Holding AG, Siegfried Holding AG, CRISPR Therapeutics AG, Dottikon Es Holding AG and Tecan Group AG.
-
What are the bottom 10 Biotechnology companies in Switzerland by Market Capitalization ?
The bottom 10 Biotechnology companies in Switzerland by Market Capitalization are NLS Pharmaceutics AG, Addex Therapeutics Ltd, Meyer Burger Technology AG, ADC Therapeutics SA, Molecular Partners AG, AC Immune SA, Metall Zug AG, Basilea Pharmaceutica AG, Kuros Biosciences AG and PolyPeptide Group AG.